471 related articles for article (PubMed ID: 33443824)
1. [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?].
Clottu A; Reinhard A; Comte D
Rev Med Suisse; 2021 Jan; 17(720-1):13-17. PubMed ID: 33443824
[TBL] [Abstract][Full Text] [Related]
2. Targeted Molecular Therapies in Allergy and Rhinology.
Damask CC; Ryan MW; Casale TB; Castro M; Franzese CB; Lee SE; Levy JM; Lin SY; Lio PA; Peters AT; Platt MP; White AA
Otolaryngol Head Neck Surg; 2021 Jan; 164(1_suppl):S1-S21. PubMed ID: 33138725
[TBL] [Abstract][Full Text] [Related]
3. Dupilumab in pediatric severe chronic rhinosinusitis with nasal polyps and asthma.
Bragança M; Pereira AM; Plácido JL; Amaral L
Eur Ann Otorhinolaryngol Head Neck Dis; 2024 Jan; 141(1):55-56. PubMed ID: 37591762
[No Abstract] [Full Text] [Related]
4. Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
Barroso B; Valverde-Monge M; Betancor D; Gómez-López A; Villalobos-Vilda C; González-Cano B; Sastre J
J Investig Allergol Clin Immunol; 2023 Dec; 33(6):419-430. PubMed ID: 37669083
[TBL] [Abstract][Full Text] [Related]
5. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
Patel GB; Peters AT
Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous Dupilumab and Mometasone Furoate Nasal Spray for Chronic Rhinosinusitis With Polyps.
Schneider JS
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):698-9. PubMed ID: 27258602
[No Abstract] [Full Text] [Related]
7. Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review.
Nitro L; Bulfamante AM; Rosso C; Saibene AM; Arnone F; Felisati G; Pipolo C
Acta Otorhinolaryngol Ital; 2022 Jun; 42(3):199-204. PubMed ID: 35880360
[TBL] [Abstract][Full Text] [Related]
8. Adverse events of biological therapy in chronic rhinosinusitis with nasal polyps: A systematic review.
Aldajani A; Alroqi A; Alromaih S; Aloulah MO; Alsaleh S
Am J Otolaryngol; 2022; 43(6):103615. PubMed ID: 36057193
[TBL] [Abstract][Full Text] [Related]
9. The Role of Biologics in the Treatment of Nasal Polyps.
Franzese CB
Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
[TBL] [Abstract][Full Text] [Related]
10. Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients.
Bandi F; Gallo S; Preti A; Mozzanica F; Visca D; Marelli M; Maddalone E; Gambarini C; Vaghi A; Spanevello A; Castelnuovo P
Acta Otorhinolaryngol Ital; 2020 Dec; 40(6):435-443. PubMed ID: 33558772
[TBL] [Abstract][Full Text] [Related]
11. Eosinophilic pulmonary complications of dupilumab in 2 patients with asthma and chronic rhinosinusitis with nasal polyps.
Frohlich M; Olivenstein R; Cormier M
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):617-619. PubMed ID: 34929373
[No Abstract] [Full Text] [Related]
12. Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy.
Papacharalampous GX; Constantinidis J; Fotiadis G; Zhang N; Bachert C; Katotomichelakis M
Int Forum Allergy Rhinol; 2024 Jan; 14(1):96-109. PubMed ID: 37394893
[TBL] [Abstract][Full Text] [Related]
13. Mepolizumab for chronic rhinosinusitis with nasal polyps.
Brusselle GG; Gevaert P
Lancet Respir Med; 2021 Oct; 9(10):1081-1082. PubMed ID: 33872589
[No Abstract] [Full Text] [Related]
14. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.
Scangas GA; Wu AW; Ting JY; Metson R; Walgama E; Shrime MG; Higgins TS
Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622
[TBL] [Abstract][Full Text] [Related]
15. Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials.
Peters AT; Soler ZM; Kern RC; Heffler E; Maspero JF; Crampette L; Fujieda S; Lane AP; Zhang H; Nash S; Khan AH; Siddiqui S; Jacob-Nara JA; Rowe P; Deniz Y
Clin Exp Allergy; 2022 Sep; 52(9):1105-1109. PubMed ID: 35775319
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives.
Okano M; Kanai K; Oka A
Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131
[TBL] [Abstract][Full Text] [Related]
18. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study.
Barroso B; Valverde-Monge M; Alobid I; Olaguibel JM; Rial MJ; Quirce S; Arismendi E; Barranco P; Betancor D; Bobolea I; Cárdaba B; Cruz Carmona MJ; Curto E; Domínguez-Ortega J; González-Barcala FJ; Martínez-Rivera C; Mahíllo-Fernández I; Muñoz X; Picado C; Plaza V; Rodrigo Muñoz JM; Soto-Retes L; Valero A; Del Pozo V; Mullol J; Sastre J
J Investig Allergol Clin Immunol; 2023 Feb; 33(1):37-44. PubMed ID: 35416154
[TBL] [Abstract][Full Text] [Related]
19. [The efficacy of omalizumab in the treatment of chronic rhinosinusitis with nasal polyps: a discussion of 2 refractory cases].
Jandus P; Harr T; Soyka MB; Landis BN
Rev Med Suisse; 2019 Oct; 15(665):1748-1751. PubMed ID: 31580018
[TBL] [Abstract][Full Text] [Related]
20. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai).
Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB
ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
